| abstract |
The invention provides novel azulene derivatives of general formula (I) wherein R1 to R6 have the significance given in the description, as well as their tautomers, enantiomers, diastereomers, racemates and physiologically compatible salts or esters and substances which are hydrolyzed or metabolised in vivo to compounds of formula (I). The invention is also concerned with a process and intermediates for the manufacture of the above compounds, medicaments which contain such compounds as well as the use of these compounds in the production of medicaments having metalloprotein-inhibiting activity. |